CENTRE LEON BERARD ( Site 4100)

Lyon, Rhone 69373

1 studies enrolling now · 1 studies all time

What they study most

Malignant Neoplasm

Studies at this site

• A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) — Recruiting now